Haydale Graphene Industries PLC Finalist for Collaborate to Innovate Awards
01 Dezember 2022 - 8:00AM
RNS Non-Regulatory
TIDMHAYD
Haydale Graphene Industries PLC
01 December 2022
REACH
For immediate release 01 December 2022
Haydale Graphene Industries plc
('Haydale' or the 'Group')
Haydale Finalist for The Engineer's Collaborate to Innovate
Awards for MicroRNA Sensor
Haydale (AIM: HAYD), the global technology solutions company, is
delighted to announce that it has been shortlisted for The
Engineer's Collaborate to Innovate Awards (C2I) for its work with
the Wales Kidney Research Unit ("WKRU") at Cardiff University on a
microRNA sensor for kidney transplant patients.
The collaborative team including Haydale, WKRU, Cardiff
University Systems Immunity Research Institute, Cardiff University
School of Medicine, Cardiff University School of Chemistry, Cardiff
and Vale University Health Board and University Hospital of Wales
are one of six finalists in the Healthcare and Medical Category for
The Engineer's seventh annual C2I Awards.
Already a winner of the Kidney Research UK MedTech Competition,
the urinary electrochemical microRNA sensor has the potential to
replace slower and more costly PCR-based methods for the rapid
detection of problems with newly transplanted kidneys. The sensor
uses Haydale's biomedical functionalised graphene ink to accelerate
detection without the need for an invasive biopsy.
This nomination will support the commercial progress that
Haydale is making with its biosensor inks, which have been focused
on diabetes monitoring and management. It is anticipated that this
will be expanded to wider diagnostics as the technology is
adopted.
Keith Broadbent, Haydale's CEO, said he was delighted the team's
hard work had been recognised, commenting:
"This is further recognition of our work in healthcare. Our
collaboration has helped to accelerate the provision of
cutting-edge technological solutions to improve people's life
experience. Using functionalised graphene reduces sensor production
time and variability and accelerates translation to improve patient
outcomes."
Dr Tim Bowen , Reader in Matrix and Molecular Biology at Wales
Kidney Research Unit, added:
"The team are delighted to be finalists for the C2I awards.
Transplants are life-changing, but when they fail the consequences
can be devastating. This urinary electrochemical microRNA sensor
technology could help identify problems earlier, leading to more
timely clinical interventions."
The very best in UK collaborations and innovations in
engineering will come together in London on Thursday 23 February
2023 for the C2I winners' party.
- Ends -
For further information:
Haydale Graphene Industries plc
Keith Broadbent, CEO Tel: +44 (0) 1269 842946
Sarah Thomas, Marketing Manager Tel: +44 (0) 1269 507026
finnCap (Nominated Adviser & Broker)
Julian Blunt / Edward Whiley, Corporate Finance Tel: +44 (0) 20
7220 0500
Andrew Burdis, ECM
Notes to Editors
Haydale is a global technologies and materials group that
facilitates the integration of graphene and other nanomaterials
into the next generation of commercial technologies and industrial
materials. With expertise in graphene, silicon carbide and other
nanomaterials, Haydale can deliver improvements in electrical,
thermal, and mechanical properties, as well as toughness through
its state-of-the-art functionalisation. Haydale has granted patents
for its technologies in Europe, USA, Australia, Japan, and China
and operates from five sites in the UK, USA, and the Far East.
For more information please visit: www.haydale.com
LinkedIn: Haydale-ltd
Twitter: @haydalegraphene
About Reach announcements
This is a Reach announcement. Reach is an investor communication
service aimed at assisting listed and unlisted (including AIM
quoted) companies to distribute non-regulatory news releases into
the public domain. Information required to be notified under the
AIM Rules for Companies, Market Abuse Regulation or other
regulation would be disseminated as an RNS regulatory announcement
and not a Reach.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAFDDFASEESEIF
(END) Dow Jones Newswires
December 01, 2022 02:00 ET (07:00 GMT)
Haydale Graphene Industr... (LSE:HAYD)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Haydale Graphene Industr... (LSE:HAYD)
Historical Stock Chart
Von Jul 2023 bis Jul 2024